Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly

Haematologica. 2003 Dec;88(12):ECR37.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoglycosides / administration & dosage
  • Aminoglycosides / therapeutic use*
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation
  • Cytarabine / administration & dosage
  • Etoposide / administration & dosage
  • Gemtuzumab
  • Humans
  • Idarubicin / administration & dosage
  • Immunotoxins / administration & dosage
  • Immunotoxins / therapeutic use*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Middle Aged
  • Recurrence
  • Salvage Therapy
  • Transplantation, Autologous

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunotoxins
  • Cytarabine
  • Etoposide
  • Gemtuzumab
  • Idarubicin